Home › Funds › SCHWARTZ INVESTMENT COUNSEL INC › DGX

SCHWARTZ INVESTMENT COUNSEL INC position in DGX

QUEST DIAGNOSTICS INC · Health Care

SCHWARTZ INVESTMENT COUNSEL INC reported holding 90,900 shares of DGX (QUEST DIAGNOSTICS INC) in its Q3 2026 13F filing — a position valued at US$21.2M, representing 0.74% of its reported portfolio and ranking #43 among its reported holdings. SCHWARTZ INVESTMENT COUNSEL INC has disclosed DGX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)90.90K sh
Reported value held$21.19M
Portfolio Weight0.74%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How SCHWARTZ INVESTMENT COUNSEL INC's DGX position evolved

SCHWARTZ INVESTMENT COUNSEL INC first disclosed a stake in DGX in Q3 2023 at 96,066 shares (US$11.7M). The position peaked in Q3 2026 at 90,900 shares, worth US$21.2M. Across 13 filings, SCHWARTZ INVESTMENT COUNSEL INC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 11 time(s). The most recent filing (Q3 2026) shows 90,900 shares valued at US$21.2M — a reduction of -5,000 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 96.07K $11.71M New
Q4 2023 96.07K $13.25M Hold
Q1 2024 96.07K $12.79M Hold
Q2 2024 96.07K $13.15M Hold
Q3 2024 96.07K $14.91M Hold
Q4 2024 95.90K $14.47M Hold
Q1 2025 95.90K $16.23M Hold
Q2 2025 95.90K $17.23M Hold
Q3 2025 95.90K $18.28M Hold
Q4 2025 95.90K $16.64M Hold
Q1 2026 95.90K $18.79M Hold
Q2 2026 95.90K $20.33M Hold
Q3 2026 90.90K $21.19M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About DGX and 13F data

DGX (QUEST DIAGNOSTICS INC) is a Health Care company. 26 other funds we track also report a position in DGX — the largest reported positions include Boston Partners (US$1.08B), EdgePoint Investment Group Inc. (US$476.4M), Grantham, Mayo, Van Otterloo & Co. LLC (US$449.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding DGX

All DGX fund holders →

FAQ

How long has SCHWARTZ INVESTMENT COUNSEL INC held DGX?

SCHWARTZ INVESTMENT COUNSEL INC has disclosed DGX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is SCHWARTZ INVESTMENT COUNSEL INC's current position in DGX?

As of Q3 2026, SCHWARTZ INVESTMENT COUNSEL INC holds 90.90K shares of DGX (QUEST DIAGNOSTICS INC), valued at $21.19M, representing 0.74% of its reported portfolio and ranking #43.

Has SCHWARTZ INVESTMENT COUNSEL INC been buying or selling DGX?

In the latest 13F filing (Q3 2026), SCHWARTZ INVESTMENT COUNSEL INC reduced its position in DGX. The position peaked in Q3 2026 at 90.90K shares.

Which other funds hold DGX?

Other major institutional holders of DGX include Boston Partners, EdgePoint Investment Group Inc., Grantham, Mayo, Van Otterloo & Co. LLC, among 26 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.